← Leaderboards
Lois B. Travis
University Of Rochester
$11,212,396
Attributed
$11,212,396
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,212,396 · 1
By mechanism
R01$11,212,396 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Rochester
Same institution · by research overlap
- Arthur J. Moss$13,356,209
- Carl T D'angio$2,710,758
- Gretchen Lano Birbeck$12,919,100
- Michael James Potchen$987,850
- Allison Marian Magnuson$3,297,377
Others in their field
Top investigators on “Publishing”
- Constance Ann Benson · University Of California, San Diego$243,271,751
- Richard K. Wilson · Washington University$201,137,538
- Norman Wolmark · Nsabp Foundation, Inc.$139,047,706
- Judith S. Currier · University Of California Los Angeles$137,892,773
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$137,892,773
- Peter C Adamson · National Childhood Cancer Foundation$108,407,802
Research focus
PublishingPlatinumPlatinum CompoundsPrevention StrategyOtotoxicityNeuropathyCytotoxic AgentCollectionFollow-UpPredispositionImpairmentHigh RiskMalignant Neoplasm Of TestisMalignant NeoplasmsCohortCisplatinCancer SurvivorAlternative TherapiesDiagnosisDoseGenetic Predisposition To DiseaseFutureGenotypeQuality Of Life
Grant awards (12)
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$780,965
R01 · FY2025 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,059,517
R01 · FY2024 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,093,680
R01 · FY2023 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,099,039
R01 · FY2022 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$336,985
R01 · FY2021 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,195,158
R01 · FY2020 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$705,222
R01 · FY2017 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1
R01 · FY2016 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$827,511
R01 · FY2015 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,189,690
R01 · FY2014 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,414,272
R01 · FY2013 · CA · contact PI
Genetic Susceptibility and Biomarkers of Platinum-related Toxicities$1,510,356
R01 · FY2012 · CA · contact PI